flucytosine has been researched along with Mycoses in 289 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
Mycoses: Diseases caused by FUNGI.
Excerpt | Relevance | Reference |
---|---|---|
"Two patients who developed fungal peritonitis after receiving continuous ambulatory peritoneal dialysis (CAPD) for various periods were successfully treated with intracatheter retention of amphotericin B and oral flucytosine for 5 weeks." | 7.69 | Intracatheter amphotericin B retention for fungal peritonitis in continuous ambulatory peritoneal dialysis. ( Chiang, SS; Hseih, SJ; Lee, SH; Shen, HM, 1995) |
" Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 7.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
"This report describes two cases of peritoneal dialysis-related peritonitis caused by Fusarium species which have been incriminated in a variety of disease conditions." | 7.68 | Fusarium peritonitis in peritoneal dialysis: report of two cases. ( Chiaradia, V; Pascoli, L; Santini, GF; Schinella, D; Tesio, F, 1990) |
"A 27-year-old man sustained a thorn injury to his left eye and a culture-proven Fusarium oxysporum endophthalmitis developed." | 7.66 | Fusarium oxysporum endophthalmitis. ( Acers, TE; Mohr, JA; Newsom, DL; Rodriguez, J; Rowsey, JJ; Smith, DL, 1979) |
"Fusarium pathogen is an uncommon cause of infections in ophthalmology." | 5.28 | [Endophthalmitis due to Fusarium: an uncommon cause]. ( Berthe-Bonnet, S; Comhaire-Poutchinian, Y; Cremer, V; Grek, V, 1990) |
"Flucytosine (5-FC), an oral antifungal agent, was used in the treatment of 37 patients with urinary tract infections due to fungi." | 5.07 | [Flucytosine in the treatment of urinary fungal infections. Clinical efficacy and background factors]. ( Ban, Y; Ehara, H; Fujihiro, S; Ito, Y; Kanematu, M; Kawada, Y; Saito, A, 1991) |
"The oral agents for deep-seated mycoses that can be used in Japan are amphotericin B, flucytosine, fluconazole, itraconazole, and voriconazole." | 4.84 | [Oral antifungal agents]. ( Maesaki, S; Tarumoto, N, 2008) |
" These events have lead to the development of new antifungal agents, and amphotericin B no longer is the standard therapy for a variety of invasive mycoses." | 4.80 | Therapy of invasive fungal infections. ( de Pauw, BE; Kullberg, BJ, 1999) |
" Amphotericin B, drug of choice for most invasive mycoses, has unique pharmacokinetic properties, binding initially to serum lipoproteins and redistributing from blood to tissues." | 4.78 | Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications. ( Lyman, CA; Walsh, TJ, 1992) |
"Flucytosine is an antifungal agent useful in combination with amphotericin B in the treatment of several deeply invasive mycoses." | 4.78 | Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy. ( Francis, P; Walsh, TJ, 1992) |
"We present six cases of fusariosis caused by Fusarium solani that were diagnosed over a three-year period in 166 adult patients undergoing chemotherapy for acute leukemia." | 4.77 | Diagnosis and successful treatment of fusariosis in the compromised host. ( Hoagland, M; Hood, AF; Jett-Goheen, M; Junkins, JM; Karp, JE; Merz, WG, 1988) |
" Two distinct eras of rapid progress in antifungal therapy followed: first, in the 1950's came the introduction of the polyenes, nystatin and pimaricin for cutaneous, vaginal and intestinal candidiasis, and amphotericin B for the treatment of severe systemic mycoses." | 4.76 | Progress in antimycotic chemotherapy 1945-1980. ( Holt, RJ, 1980) |
"Two patients who developed fungal peritonitis after receiving continuous ambulatory peritoneal dialysis (CAPD) for various periods were successfully treated with intracatheter retention of amphotericin B 1-2 mg and oral flucytosine or fluconazole 50 mg b." | 3.69 | Successful treatment of fungal peritonitis with intracatheter antifungal retention. ( Chiang, SS; Hseih, SJ; Lee, SH; Shen, HM, 1995) |
"Two patients who developed fungal peritonitis after receiving continuous ambulatory peritoneal dialysis (CAPD) for various periods were successfully treated with intracatheter retention of amphotericin B and oral flucytosine for 5 weeks." | 3.69 | Intracatheter amphotericin B retention for fungal peritonitis in continuous ambulatory peritoneal dialysis. ( Chiang, SS; Hseih, SJ; Lee, SH; Shen, HM, 1995) |
" Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 3.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
"This report describes two cases of peritoneal dialysis-related peritonitis caused by Fusarium species which have been incriminated in a variety of disease conditions." | 3.68 | Fusarium peritonitis in peritoneal dialysis: report of two cases. ( Chiaradia, V; Pascoli, L; Santini, GF; Schinella, D; Tesio, F, 1990) |
"Combination pairs of 5-fluorocytosine (5-FC) + itraconazole (Itra), 5-FC + fluconazole (Fluc), and amphotericin B (Amph B) + Itra were administered to mice with experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis with a variety of combination ratios." | 3.67 | Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. ( Polak, A, 1987) |
"Numerous progresses are realized in the chemotherapy of mycoses, particularly in the field of deep mycoses due to 3 categories of systemic antifungal agents: polyenes (oral nystatin, oral and intravenous amphotericin B), 5-fluorocytosine (oral and intravenous) and imidazole derivatives (oral and intravenous miconazole, oral ketoconazole)." | 3.66 | [Antifungal agents in otorhinolaryngology]. ( Drouhet, E; Dupont, B, 1982) |
"The author presents the drugs that are available for the treatment of opportunistic mycoses: amphotericin B, nystatin, 5-fluorocytosine, miconazole and the newest imidazole derivative econazole." | 3.66 | [Therapy of opportunistic mycoses]. ( Negroni, R, 1979) |
" Despite surgical excision and therapy with the antifungal drugs amphotericin B and flucytosine, the case had a fatal outcome, the patient dying from a pulmonary embolism 6 mth after the onset of symptoms." | 3.66 | Cerebral abscess caused by Cladosporium bantianum. Case report. ( Wilson, E, 1982) |
"A 27-year-old man sustained a thorn injury to his left eye and a culture-proven Fusarium oxysporum endophthalmitis developed." | 3.66 | Fusarium oxysporum endophthalmitis. ( Acers, TE; Mohr, JA; Newsom, DL; Rodriguez, J; Rowsey, JJ; Smith, DL, 1979) |
" Amphotericin B is the single most important antifungal agent for the treatment of systemic mycoses." | 3.66 | Drugs for fungal infections. ( Yoshikawa, TT, 1980) |
"Two different flucytosine (5-FC) treatment regimens, one by itself and the other in combination with fluconazole (FLCZ) were compared in chemotherapy against mycotic infections in 60 patients with hematological diseases." | 2.67 | [A comparative clinical study on flucytosine alone and in combination with fluconazole in hematological malignancies: a multicenter study using the envelope method]. ( Ariyoshi, H; Hamajima, N; Hotta, T; Kodera, Y; Murate, T; Naito, K; Naoe, T; Ogura, M; Saito, H; Tanaka, M, 1994) |
" Antimicrobial pharmacokinetic/pharmacodynamic (PK/PD) studies consider these variables and have been useful in drug development, optimizing dosing regimens, determining susceptibility breakpoints, and limiting toxicity of antifungal therapy." | 2.50 | Antifungal pharmacokinetics and pharmacodynamics. ( Andes, DR; Lepak, AJ, 2014) |
" This article reviews the pharmacokinetic profiles of these drugs in children, with a focus on the age-related changes." | 2.47 | [Pharmacokinetics and pharmacodynamics of antifungal drugs in children]. ( Jullien, V, 2011) |
" Antifungal serum concentrations may aid in the determination of appropriate dosing in select circumstances." | 2.44 | Antifungal serum concentration monitoring: an update. ( Drew, RH; Goodwin, ML, 2008) |
"Therapeutic drug monitoring of any pharmacologic agent should be considered when there is both significant pharmacokinetic variability and strong, clinically relevant, exposure-effect relationships." | 2.44 | Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations. ( Andes, D; Smith, J, 2008) |
"Amphotericin B was the standard of care for most of these infections." | 2.43 | Management of systemic fungal infections: alternatives to itraconazole. ( Fohrer, C; Herbrecht, R; Letscher-Bru, V; Natarajan-Amé, S; Nivoix, Y, 2005) |
"Invasive fungal infections have increased in frequency and severity over the past two decades as a result of an increasing number of immunocompromised patients." | 2.43 | Antifungal treatment in pediatric patients. ( Benjamin, DK; Steinbach, WJ; Zaoutis, TE, 2005) |
" This article provides an up-to-date review on the clinical pharmacology, indications, and dosage recommendations of approved and currently investigational therapeutics for treatment of invasive fungal infections in adult and pediatric patients." | 2.42 | Clinical pharmacology of antifungal compounds. ( Gea-Banacloche, JC; Glasmacher, A; Groll, AH; Just-Nuebling, G; Maschmeyer, G; Walsh, TJ, 2003) |
"Fungal infections are life-threatening complications in patients with prolonged neutropenia." | 2.41 | Standard antifungal therapy in neutropenic patients. ( Aoun, M, 2000) |
"Amphotericin B has a broad spectrum and has remained the drug of choice for these life threatening invasive fungal infections." | 2.41 | [Choice and use of antifungal drugs]. ( Dupont, B, 2001) |
" 5-FC is well absorbed after oral administration, penetrates into body tissues well and is excreted mainly by the kidneys." | 2.41 | Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. ( Dankert, J; Guchelaar, HJ; Vermes, A, 2000) |
" The bioavailability of fluconazole is much less varied although validation of compliance is a situation where obtaining serum concentrations may provide additional information." | 2.40 | Therapeutic drug monitoring of systemic antifungal therapy. ( Gore, SJ; Graybill, JR; Hardin, TC; Summers, KK, 1997) |
"Fungal infections have emerged as a major complication of marrow transplantation in children." | 2.39 | Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients. ( Chanock, SJ; Walsh, TJ, 1996) |
" Liposomal Amphotericin B allowing higher dosage by lower toxicity appears effective as salvage treatment especially in aspergillosis which also responds to Itraconazole available as oral formulation so far." | 2.38 | Antifungal treatment strategy in leukemia patients. ( Büchner, T; Roos, N, 1992) |
"Treatment with amphotericin B and 5-fluorocytosine was initiated." | 2.38 | Cerebral phaeohyphomycosis caused by Xylohypha bantiana, with a review of the literature. ( Galbraith, J; Garg, AK; Mielke, BW; Sekhon, AS; Sheehan, G, 1992) |
"Systemic fungal infections are life-threatening diseases that are occurring with increasing frequency, especially in immunocompromised patients." | 2.37 | Recent advances in the treatment of systemic fungal infections. ( Walsh, TJ, 1987) |
"Superficial fungal infections are frequent and can cause considerable morbidity." | 2.37 | Topical and systemic antifungal agents. ( Bodey, GP, 1988) |
"The deep mycoses are increasing in importance both as opportunistic infections and from exposure in geographically defined areas." | 2.37 | Cutaneous and mucosal manifestations of the deep mycotic infections. ( Meyer, RD, 1986) |
"Flucytosine is a systemic antifungal drug that is readily absorbed from the gastrointestinal tract." | 2.36 | Flucytosine. ( Bennet, JE, 1977) |
"Amphotericin B has remained the most effective therapeutic preparation for most types of neurological fungal disease, although important roles for 5-fluorocytosine, miconazole, and, more recently, ketoconazole are being recognized." | 2.36 | Treatment of fungal infections of the central nervous system. ( Bell, WE, 1981) |
"Miconazole is a parenterally administered agent for patients acutely ill with candidiasis and other mycotic infections." | 2.36 | Antifungal agents used in systemic mycoses. Activity and therapeutic use. ( Craven, PC; Graybill, JR, 1983) |
"Micafungin was active against species of Candida and Aspergillus (even azole-resistant species) as well as Penicillium spp." | 1.35 | Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds. ( Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL, 2009) |
"5-flucytosine (5-FC) is an antifungal drug used for the treatment of serious infections caused by Candida or Cryptococcus spp." | 1.33 | Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory. ( Bowker, KE; Lovering, AM; MacGowan, AP; Soltani, M; Sunderland, J; Tobin, CM, 2006) |
"Posaconazole was the most active of antifungal agents tested against Aspergillus spp." | 1.33 | Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. ( Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL, 2006) |
"Systemic fungal infections are rare." | 1.31 | Systemic phaeohyphomycosis in pregnancy and the puerperium. ( East-Innis, A; Fletcher, H; Nicholson, A; Phillip, H; Rainford, L; Williams, NP, 2000) |
"Diagnosis and treatment of fungal infections in medical and surgical intensive care units are controversial issues." | 1.31 | [Fungal infections in intensive care units: a cross-survey]. ( Dupont, H, 2001) |
"Yeast fungemia has increased markedly in the last few years." | 1.30 | [A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)]. ( Cuenca-Estrella, M; Rodríguez-Tudela, JL, 1999) |
"Voriconazole was most active against P." | 1.30 | Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi. ( Jones, RN; Marco, F; Messer, SA; Pfaller, MA, 1998) |
" Lipid preparations of amphotericin B have reduced the toxicity of this agent, but some issues of dosage and efficacy remain." | 1.30 | Therapy of deep fungal infection in haematological malignancy. Working Party of the British Society for Antimicrobial Chemotherapy. ( , 1997) |
"Amphotericin B was very active (MIC90 < or = 1." | 1.29 | In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method. ( Barry, AL; Pfaller, MA, 1995) |
"Miconazole, which was tested only with P." | 1.29 | Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. ( Gehrt, A; Peter, J; Pizzo, PA; Walsh, TJ, 1995) |
" In conclusion, from a pharmacokinetic point of view, all the antifungal agents examined, perhaps with the exception of F, do not offer, when used alone, sufficient guarantees in curing peritonitis." | 1.29 | Pharmacokinetics of antifungal agents. ( Bolzonella, R; Contestabile, A; Fabris, A; Gardin, C; Pellanda, MV, 1993) |
"The results in histoplasmosis are encouraging, as are the results in chromomycosis, particularly those cases associated with Cladosporium carrionii." | 1.28 | Tropical mycoses. ( Bayles, MA, 1992) |
"Fungal infections have become one of the major causes of death among immunocompromised patients, particularly patients with AIDS." | 1.28 | Treating systemic fungal infections in AIDS patients. Prolonging life against the odds. ( Scheld, WM, 1990) |
" We also recommend an initial 24-hour dosing interval for amphotericin B and 5-fluorocytosine." | 1.28 | Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates. ( Baley, JE; Blumer, JL; Jacobs, MR; Kliegman, RM; Meyers, C, 1990) |
"Treatment with amphotericin B, flucytosine and high doses of fluconazole was followed by clinical improvement, although CSF pleocytosis remained." | 1.28 | First report of chronic meningitis caused by Trichosporon beigelii. ( Boogaerts, M; Marcelis, L; Surmont, I; Verbist, L; Vergauwen, B; Verhoef, G, 1990) |
"Fluconazole is a triazole antifungal compound with a very original distribution to the meninges and urinary tract; it is mainly used in candidiasis and cryptococcosis." | 1.28 | [Treatment of mycoses and new antifungal agents]. ( Dupont, B, 1989) |
"Fusarium pathogen is an uncommon cause of infections in ophthalmology." | 1.28 | [Endophthalmitis due to Fusarium: an uncommon cause]. ( Berthe-Bonnet, S; Comhaire-Poutchinian, Y; Cremer, V; Grek, V, 1990) |
" Although appropriate therapy of fungal peritonitis in patients undergoing CAPD still remains controversial, both for the drug of choice and for the dosage to be used, our study indicates that a 5-week course of oral 5-fluorocytosine (5-FC) may obviate the need to remove the peritoneal catheter during the management of peritonitis caused by susceptible strains of T glabrata." | 1.27 | Torulopsis glabrata peritonitis complicating continuous ambulatory peritoneal dialysis: successful management with oral 5-fluorocytosine. ( Cecchin, E; Chiaradia, V; De Marchi, S; Franceschin, A; Panarello, G; Santini, G; Tesio, F, 1984) |
" It is clearly seen from the table that the optimal modern therapy of systemic mycoses is a combination of 5-fluorocytosine in a normal dosage and amphotericin B at reduced dosage." | 1.27 | [Antimycotic chemotherapy in weakened resistance]. ( Wegmann, T, 1984) |
"BAY N 7133 was also effective for mouse candidosis by parenteral administration and was effective for guinea pig trichophytosis on topical application." | 1.27 | Antimycotic activity of BAY N 7133 in animal experiments. ( Plempel, M, 1984) |
"Treatment with amphotericin B, 5-fluorocytosine, and splenectomy proved successful." | 1.27 | Successful treatment of disseminated Trichosporon beigelii (cutaneum) infection with associated splenic involvement. ( Bhansali, S; Crane, L; Karanes, C; Kiel, R; Palutke, W; Ratanatharathorn, V, 1986) |
"Multiple phaeohyphomycotic brain abscesses caused by Cladosporium species occurred in a 55 year old woman." | 1.27 | Cerebral phaeohyphomycosis. ( Abu Aisha, H; Chagla, AH; Laajam, M; Yaqoub, B, 1987) |
"Miconazole was found to be an effective agent in some patients when administered in a dosage of 2400 mg/day." | 1.27 | Fungal endophthalmitis in narcotic abusers. Medical and surgical therapy in 10 patients. ( Billson, F; Clifton-Bligh, P; Gallo, J; Gregory-Roberts, J; Grunstein, H; Playfair, J, 1985) |
"Ketoconazole was administered orally at daily dosages of 400-800 mg; 5-fluorocytosine was associated in four cases." | 1.27 | Ketoconazole: clinical evaluation in severe fungal infections. ( Arosio, E; Dean, P; Lechi, A; Montesi, G; Pancera, P, 1986) |
"Our patient had a brain abscess and paranasal sinus infection due to C trichoides." | 1.26 | Brain abscess caused by Cladosporium trichoides (Bantianum): a case with paranasal sinus involvement. ( Brown, JW; Nadell, J; Sanders, CV; Sardenga, L, 1976) |
"Three cases, one of mycetoma, one of chromomycosis, one of histoplasmosis, are described." | 1.26 | Mycoses imported from the West Indies. A report of three cases. ( Hay, RJ, 1979) |
" In three patients, accumulation of toxic levels of 5-FC was related to diminished renal function." | 1.26 | Bone marrow toxicity associated with 5-fluorocytosine therapy. ( Frame, PT; Kauffman, CA, 1977) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 166 (57.44) | 18.7374 |
1990's | 75 (25.95) | 18.2507 |
2000's | 39 (13.49) | 29.6817 |
2010's | 8 (2.77) | 24.3611 |
2020's | 1 (0.35) | 2.80 |
Authors | Studies |
---|---|
Serena, C | 1 |
Rodríguez, MM | 1 |
Mariné, M | 2 |
Pastor, FJ | 2 |
Guarro, J | 4 |
Cuenca-Estrella, M | 7 |
Gomez-Lopez, A | 4 |
Gutierrez, MO | 1 |
Buitrago, MJ | 3 |
Rodriguez-Tudela, JL | 5 |
Mellado, E | 2 |
Monzon, A | 2 |
Kathiravan, MK | 1 |
Salake, AB | 1 |
Chothe, AS | 1 |
Dudhe, PB | 1 |
Watode, RP | 1 |
Mukta, MS | 1 |
Gadhwe, S | 1 |
Johnson, MD | 1 |
Chiron, LM | 1 |
Pihet, M | 1 |
Rouleau, F | 1 |
de Gentile, L | 1 |
Bouchara, JP | 1 |
Chabasse, D | 1 |
Lepak, AJ | 1 |
Andes, DR | 1 |
Delarze, E | 1 |
Sanglard, D | 2 |
Narendran, N | 1 |
Balasubramaniam, B | 1 |
Johnson, E | 1 |
Dick, A | 1 |
Mayer, E | 1 |
Tarumoto, N | 1 |
Maesaki, S | 2 |
Araujo Ribeiro, M | 1 |
Alastruey-Izquierdo, A | 1 |
Pemán, J | 1 |
Cantón, E | 1 |
Espinel-Ingroff, A | 2 |
Ruiz-Camps, I | 1 |
Houbraken, J | 1 |
Verweij, PE | 1 |
Rijs, AJ | 1 |
Borman, AM | 1 |
Samson, RA | 1 |
Jullien, V | 1 |
Kontoyiannis, DP | 1 |
Clerihew, L | 1 |
McGuire, W | 1 |
Silverberg, D | 1 |
Kodali, P | 1 |
Dipersio, J | 1 |
Acus, R | 1 |
Askew, M | 1 |
Olver, WJ | 1 |
James, SA | 1 |
Lennard, A | 1 |
Galloway, A | 1 |
Roberts, IN | 1 |
Boswell, TC | 1 |
Russell, NH | 1 |
Loeffler, J | 1 |
Stevens, DA | 2 |
Polak, A | 4 |
Groll, AH | 1 |
Gea-Banacloche, JC | 1 |
Glasmacher, A | 2 |
Just-Nuebling, G | 1 |
Maschmeyer, G | 1 |
Walsh, TJ | 9 |
Fehér, J | 1 |
Lengyel, G | 1 |
Negroni, R | 2 |
Helou, SH | 1 |
Petri, N | 1 |
Robles, AM | 1 |
Arechavala, A | 1 |
Bianchi, MH | 1 |
Komatsu, M | 1 |
Aihara, M | 1 |
Shimakawa, K | 1 |
Iwasaki, M | 1 |
Nagasaka, Y | 1 |
Fukuda, S | 1 |
Abe, N | 1 |
Matsuo, S | 1 |
Ozçelik, B | 1 |
Citak, S | 1 |
Cesur, S | 1 |
Abbasoğlu, U | 1 |
Içli, F | 1 |
Steinbach, WJ | 2 |
Zaoutis, TE | 1 |
Benjamin, DK | 1 |
Herbrecht, R | 1 |
Nivoix, Y | 1 |
Fohrer, C | 1 |
Natarajan-Amé, S | 1 |
Letscher-Bru, V | 1 |
Braun, JJ | 1 |
Pauli, G | 1 |
de Blay, F | 1 |
Burkert, M | 1 |
Fuhr, HG | 1 |
Mertelsmann, R | 1 |
Kendirli, T | 1 |
Ciftçi, E | 1 |
Ince, E | 1 |
Oncel, S | 1 |
Dalgiç, N | 1 |
Güriz, H | 1 |
Unal, E | 1 |
Dogru, U | 1 |
Soltani, M | 1 |
Tobin, CM | 1 |
Bowker, KE | 1 |
Sunderland, J | 1 |
MacGowan, AP | 1 |
Lovering, AM | 1 |
Makimura, K | 1 |
Hara, S | 1 |
Yokote, T | 1 |
Oka, S | 1 |
Akioka, T | 1 |
Kobayashi, K | 1 |
Hirata, Y | 1 |
Miyoshi, T | 1 |
Tsuji, M | 1 |
Hanafusa, T | 1 |
Chen, SC | 1 |
Sorrell, TC | 1 |
Goodwin, ML | 1 |
Drew, RH | 1 |
Smith, J | 1 |
Andes, D | 1 |
Lefrock, JL | 1 |
Smith, BR | 1 |
Padhye, AA | 2 |
Kaplan, W | 1 |
Neuman, MA | 1 |
Case, P | 1 |
Radcliffe, GN | 1 |
Takeuchi, H | 2 |
Arai, Y | 1 |
Konami, T | 1 |
Ikeda, T | 1 |
Tomoyoshi, T | 2 |
Tatewaki, K | 1 |
Seaworth, BJ | 1 |
Kwon-Chung, KJ | 2 |
Hamilton, JD | 2 |
Perfect, JR | 1 |
Arai, T | 2 |
Roberts, DT | 1 |
Höffken, G | 1 |
Lode, H | 1 |
Graybill, JR | 3 |
Craven, PC | 1 |
Brabender, W | 1 |
Hodges, GR | 1 |
Stamm, AM | 1 |
Dismukes, WE | 1 |
Medoff, G | 6 |
Brajtburg, J | 1 |
Kobayashi, GS | 5 |
Bolard, J | 1 |
Plempel, M | 3 |
Rusthoven, JJ | 1 |
Feld, R | 1 |
Tuffnell, PG | 1 |
Koldin, MH | 1 |
Hermans, PE | 2 |
Keys, TF | 1 |
Uno, H | 1 |
Clemente González, C | 1 |
Kostiala, AA | 1 |
Kostiala, I | 1 |
Kambayashi, J | 1 |
Ogawa, Y | 1 |
Kosaki, G | 1 |
Bossa, R | 1 |
Galatulas, I | 1 |
Wegmann, T | 5 |
Cecchin, E | 3 |
Panarello, G | 3 |
De Marchi, S | 3 |
Droller, DD | 1 |
Franceschin, A | 1 |
Chiaradia, V | 2 |
Santini, G | 1 |
Tesio, F | 3 |
Korinek, JK | 1 |
Guarda, LA | 1 |
Bolivar, R | 1 |
Stroehlein, JR | 1 |
Oelz, O | 2 |
Schaffner, A | 1 |
Frick, P | 1 |
Schaer, G | 1 |
Gross, M | 1 |
Baley, JE | 2 |
Kliegman, RM | 2 |
Fanaroff, AA | 1 |
Hay, RJ | 2 |
Kaell, AT | 1 |
Weitzman, I | 2 |
Qadripur, SA | 1 |
Yoshikawa, TT | 1 |
Holt, RJ | 2 |
Bell, WE | 1 |
Utz, JP | 7 |
Wilson, E | 1 |
Watanakunakorn, C | 1 |
Roselle, GA | 1 |
Dupont, B | 6 |
Drouhet, E | 2 |
Pizzo, PA | 2 |
László, A | 1 |
Ikemoto, H | 3 |
Riyat, MS | 1 |
Vazzana, A | 1 |
Sandven, P | 2 |
Rohner, TJ | 1 |
Tuliszewski, RM | 1 |
Corrado, ML | 1 |
Stanek, A | 1 |
Goetz, R | 1 |
Agyare, E | 1 |
Lee, SH | 2 |
Chiang, SS | 2 |
Hseih, SJ | 2 |
Shen, HM | 2 |
Gehrt, A | 1 |
Peter, J | 1 |
Pfaller, MA | 2 |
Barry, AL | 1 |
Vanden Bossche, H | 1 |
Warnock, DW | 1 |
Kerridge, D | 2 |
Sen Gupta, S | 1 |
Improvisi, L | 1 |
Marichal, P | 1 |
Odds, FC | 1 |
Provost, F | 1 |
Ronin, O | 1 |
Viviani, MA | 1 |
Naito, K | 1 |
Murate, T | 1 |
Hotta, T | 1 |
Saito, H | 1 |
Hamajima, N | 1 |
Naoe, T | 1 |
Ogura, M | 1 |
Ariyoshi, H | 1 |
Tanaka, M | 1 |
Kodera, Y | 1 |
Pogliani, E | 1 |
Clini, E | 1 |
Amici, G | 1 |
Grandesso, S | 1 |
Mottola, A | 1 |
Virga, G | 1 |
Teodori, T | 1 |
Maresca, MC | 1 |
Bocci, C | 1 |
Lynch, ME | 1 |
Sobel, JD | 1 |
Björkholm, M | 1 |
Bickers, DR | 1 |
Michel, C | 1 |
Courdavault, L | 1 |
al Khayat, R | 1 |
Viron, B | 1 |
Roux, P | 1 |
Mignon, F | 1 |
Yamaguchi, H | 1 |
Uchida, K | 1 |
Palaoglu, S | 1 |
Sav, A | 1 |
Basak, T | 1 |
Yalcinlar, Y | 1 |
Scheithauer, BW | 1 |
Supparatpinyo, K | 1 |
Nelson, KE | 1 |
Merz, WG | 2 |
Breslin, BJ | 1 |
Cooper, CR | 1 |
Kamwan, C | 1 |
Sirisanthana, T | 1 |
Aoba, S | 1 |
Komiyama, A | 1 |
Hasegawa, O | 1 |
Fabris, A | 1 |
Pellanda, MV | 1 |
Gardin, C | 1 |
Contestabile, A | 1 |
Bolzonella, R | 1 |
Lyman, CA | 2 |
Guiserix, J | 1 |
Ramdane, M | 1 |
Finielz, P | 1 |
Michault, A | 1 |
Rajaonarivelo, P | 1 |
Chanock, SJ | 1 |
Kubo, N | 1 |
Hiramitsu, S | 1 |
Morimoto, S | 1 |
Hood, SV | 1 |
Moore, CB | 1 |
Cheesbrough, JS | 1 |
Mene, A | 1 |
Denning, DW | 1 |
Tiballi, RN | 1 |
Spiegel, JE | 1 |
Zarins, LT | 1 |
Kauffman, CA | 2 |
Berenguer Berenguer, J | 1 |
Summers, KK | 1 |
Hardin, TC | 1 |
Gore, SJ | 1 |
Just-Nübling, G | 1 |
Molitor, E | 1 |
Rex, JH | 1 |
Anaissie, EJ | 1 |
Andriole, VT | 1 |
Watanabe, K | 2 |
Marco, F | 1 |
Messer, SA | 1 |
Jones, RN | 1 |
Pujol, I | 1 |
Mayayo, E | 1 |
de Pauw, BE | 2 |
Meunier, F | 1 |
Hossain, MA | 1 |
Sasaki, E | 1 |
Hashiguchi, K | 1 |
Higashiyama, Y | 1 |
Yoshitsugu, Y | 1 |
Tomono, K | 1 |
Tashiro, T | 1 |
Kohno, S | 1 |
Kullberg, BJ | 1 |
Marwaha, RK | 1 |
Maheshwari, A | 1 |
Fletcher, H | 1 |
Williams, NP | 1 |
Nicholson, A | 1 |
Rainford, L | 1 |
Phillip, H | 1 |
East-Innis, A | 1 |
Cawley, MJ | 1 |
Braxton, GR | 1 |
Haith, LR | 1 |
Reilly, KJ | 1 |
Guilday, RE | 1 |
Patton, ML | 1 |
Rimek, D | 1 |
Zimmermann, T | 1 |
Hartmann, M | 1 |
Prariyachatigul, C | 1 |
Kappe, R | 1 |
Silling, G | 1 |
Fegeler, W | 1 |
Roos, N | 2 |
Essink, M | 1 |
Büchner, T | 2 |
Vermes, A | 1 |
Guchelaar, HJ | 1 |
Dankert, J | 1 |
Lieberman, TW | 1 |
Leopold, IH | 1 |
Aoun, M | 1 |
Llop, C | 1 |
Sala, J | 1 |
Riba, MD | 1 |
André, MH | 1 |
Lortholary, O | 1 |
Dupont, H | 1 |
Rivera, R | 1 |
Cangir, A | 1 |
Tan, RJ | 1 |
Lim, EW | 1 |
Ishak, B | 1 |
Hecht, R | 1 |
Montgomerie, JZ | 1 |
Codish, SD | 2 |
Sheridan, ID | 1 |
Monaco, AP | 2 |
Jones, DB | 1 |
Rowsey, JJ | 1 |
Acers, TE | 1 |
Smith, DL | 1 |
Mohr, JA | 1 |
Newsom, DL | 1 |
Rodriguez, J | 1 |
Bennet, JE | 1 |
Ashe, WD | 1 |
Van Reken, DE | 1 |
Ata, H | 1 |
Hoeprich, PD | 1 |
Tobias, JS | 1 |
Norrby, R | 2 |
Eilard, T | 2 |
Baum, GL | 1 |
Coodley, EL | 1 |
Lapresle, C | 1 |
Wain, W | 1 |
Ahmed, M | 1 |
Thompson, R | 1 |
Yacoub, M | 1 |
Muther, RS | 1 |
Bennett, WM | 1 |
Block, CS | 1 |
Young, CN | 1 |
Myers, RA | 1 |
Kraatz, G | 1 |
Bernhardt, H | 1 |
Ranft, R | 1 |
Aurich, G | 4 |
Plenert, W | 3 |
Male, O | 1 |
Bergan, T | 1 |
Krick, JA | 2 |
Remington, JS | 2 |
Beskow, D | 1 |
Wåhlén, P | 1 |
Alestig, K | 1 |
Michigan, S | 1 |
Frame, PT | 1 |
Hofstetter, A | 1 |
Schönebeck, J | 1 |
Middleton, FG | 1 |
Jurgenson, PF | 1 |
Shadomy, S | 2 |
Shadomy, HJ | 1 |
Lutwick, LI | 1 |
Galgiani, JN | 1 |
Johnson, RH | 1 |
Feuerstein, M | 1 |
Plennert, W | 1 |
Zintl, F | 1 |
Brown, JW | 1 |
Nadell, J | 1 |
Sanders, CV | 1 |
Sardenga, L | 1 |
Gallis, HA | 1 |
Berman, RA | 1 |
Cate, TR | 1 |
Gunnells, JC | 1 |
Stickel, DL | 1 |
Salit, I | 1 |
Hand, R | 1 |
Drevets, CC | 1 |
Hummer, LM | 1 |
Rubinstein, E | 1 |
Noriega, ER | 1 |
Simberkoff, MS | 1 |
Holzman, R | 1 |
Rahal, JJ | 1 |
Meinhof, W | 1 |
Würsten, D | 1 |
Bayles, MA | 1 |
Van Cutsem, J | 1 |
Kujala, P | 1 |
Ruutu, P | 1 |
Sekhon, AS | 2 |
Galbraith, J | 1 |
Mielke, BW | 1 |
Garg, AK | 1 |
Sheehan, G | 1 |
Naidu, J | 1 |
Singh, SM | 1 |
Sudduth, EJ | 1 |
Crumbley, AJ | 1 |
Farrar, WE | 1 |
Tokunaga, S | 1 |
Ohkawa, M | 1 |
Nakashima, T | 1 |
Yamaguchi, K | 1 |
Nishikawa, T | 1 |
Matsushita, T | 1 |
Mikawa, I | 1 |
Hirano, S | 1 |
Kawaguchi, S | 1 |
Miyagi, T | 1 |
Francis, P | 1 |
Terrell, CL | 2 |
Hughes, CE | 1 |
Nielsen, H | 1 |
Stenderup, J | 1 |
Bruun, B | 1 |
Sides, EH | 1 |
Benson, JD | 1 |
Fujihiro, S | 1 |
Ehara, H | 1 |
Saito, A | 1 |
Ito, Y | 1 |
Kanematu, M | 1 |
Ban, Y | 1 |
Kawada, Y | 1 |
Koppang, HS | 1 |
Olsen, I | 1 |
Stuge, U | 1 |
Comhaire-Poutchinian, Y | 1 |
Berthe-Bonnet, S | 1 |
Grek, V | 1 |
Cremer, V | 1 |
Wolf, HH | 1 |
Scharf, RE | 1 |
Arning, M | 1 |
Schneider, W | 1 |
Scheld, WM | 1 |
Schinella, D | 1 |
Pascoli, L | 1 |
Santini, GF | 1 |
Meyers, C | 1 |
Jacobs, MR | 1 |
Blumer, JL | 1 |
Surmont, I | 1 |
Vergauwen, B | 1 |
Marcelis, L | 1 |
Verbist, L | 1 |
Verhoef, G | 1 |
Boogaerts, M | 1 |
Ogata, K | 1 |
Tanabe, Y | 1 |
Iwakiri, K | 1 |
Ito, T | 1 |
Yamada, T | 1 |
Dan, K | 1 |
Nomura, T | 1 |
Mitchell, DM | 1 |
Fitz-Henley, M | 1 |
Horner-Bryce, J | 1 |
Ette, A | 1 |
Bamba, M | 1 |
Adjoua, P | 1 |
Boguifo, J | 1 |
Ette, EE | 1 |
Fakhry, K | 1 |
Therizol, MF | 1 |
Guarner, J | 1 |
Del Rio, C | 1 |
Williams, P | 1 |
McGowan, JE | 1 |
Mocan, H | 1 |
Murphy, AV | 1 |
Beattie, TJ | 1 |
McAllister, TA | 1 |
Pizzo, A | 1 |
Murphy, N | 1 |
Buchanan, CR | 1 |
Damjanovic, V | 1 |
Whitaker, R | 1 |
Hart, CA | 1 |
Cooke, RW | 1 |
Zimmermann-Hölsi, MB | 1 |
Stahel, RA | 1 |
Vogt, P | 1 |
Karp, JE | 1 |
Hoagland, M | 1 |
Jett-Goheen, M | 1 |
Junkins, JM | 1 |
Hood, AF | 1 |
Tang, LM | 1 |
Ryu, SJ | 1 |
Chen, TJ | 1 |
Cheng, SY | 1 |
Mina, FA | 1 |
Hopkins, SJ | 1 |
Richelo, B | 1 |
Bodey, GP | 1 |
Donald, FE | 1 |
Sharp, JF | 1 |
Firth, JL | 1 |
Crowley, JL | 1 |
Ispahani, P | 1 |
van 't Wout, JW | 1 |
van Furth, R | 1 |
Bhansali, S | 1 |
Karanes, C | 1 |
Palutke, W | 1 |
Crane, L | 1 |
Kiel, R | 1 |
Ratanatharathorn, V | 1 |
Meyer, RD | 1 |
Washida, H | 1 |
Tsugaya, M | 1 |
Hirao, N | 1 |
Sakagami, H | 1 |
Iwase, Y | 1 |
Abu Aisha, H | 1 |
Laajam, M | 1 |
Yaqoub, B | 1 |
Chagla, AH | 1 |
Tapson, JS | 1 |
Mansy, H | 1 |
Freeman, R | 1 |
Wilkinson, R | 1 |
Edwards, R | 1 |
Birrell, LN | 1 |
Finch, RG | 1 |
Gallo, J | 1 |
Playfair, J | 1 |
Gregory-Roberts, J | 1 |
Grunstein, H | 1 |
Clifton-Bligh, P | 1 |
Billson, F | 1 |
Yang, DJ | 1 |
Rankin, GO | 1 |
Lechi, A | 1 |
Montesi, G | 1 |
Dean, P | 1 |
Pancera, P | 1 |
Arosio, E | 1 |
Johnson, RJ | 1 |
Ramsey, PG | 1 |
Gallagher, N | 1 |
Ahmad, S | 1 |
Benevent, D | 1 |
Peyronnet, P | 1 |
Lagarde, C | 1 |
Leroux-Robert, C | 1 |
Willans, DJ | 1 |
Harvey, JH | 1 |
O'Grady, F | 1 |
Clayton, YM | 1 |
Riley, HD | 2 |
Reznikova, MM | 1 |
Agarunova, IuS | 1 |
Harford, CG | 1 |
Brunner, J | 1 |
Engeler, V | 1 |
Firkin, FC | 1 |
Newberry, WM | 1 |
Smith, JW | 1 |
Abernathy, RS | 1 |
Bennett, JE | 3 |
Block, ER | 2 |
Jennings, AE | 1 |
Fishbach, RS | 1 |
White, ML | 1 |
Finegold, SM | 1 |
Livoti, LG | 1 |
Klein, WJ | 1 |
MacGregor, RR | 1 |
Henderson, L | 1 |
95 reviews available for flucytosine and Mycoses
Article | Year |
---|---|
The biology and chemistry of antifungal agents: a review.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Imidazoles; Mycoses | 2012 |
Antifungals in Clinical Use and the Pipeline.
Topics: Antifungal Agents; Azoles; Drugs, Investigational; Echinocandins; Flucytosine; Humans; Mycoses; Poly | 2021 |
Antifungal pharmacokinetics and pharmacodynamics.
Topics: Animals; Antifungal Agents; Disease Models, Animal; Echinocandins; Flucytosine; Humans; Mice; Mycose | 2014 |
Defining the frontiers between antifungal resistance, tolerance and the concept of persistence.
Topics: Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Drug T | 2015 |
[Oral antifungal agents].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucyt | 2008 |
Antifungal drug resistance mechanisms.
Topics: Antifungal Agents; Azoles; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Flucytosine | 2009 |
[Antifungals for systemic use].
Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Drug Therapy, Combination; Drugs, Investigationa | 2009 |
[Pharmacokinetics and pharmacodynamics of antifungal drugs in children].
Topics: Amphotericin B; Antifungal Agents; Child; Echinocandins; Evidence-Based Medicine; Flucytosine; Human | 2011 |
Invasive mycoses: strategies for effective management.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Antifungal Agents; Antineoplastic Agents; Asparta | 2012 |
Antifungal therapy for newborn infants with invasive fungal infection.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Infant, Newborn; Infant, Premat | 2012 |
Clinical relevance of mechanisms of antifungal drug resistance in yeasts.
Topics: Antifungal Agents; Azoles; Biological Transport; Candidiasis; Drug Resistance, Fungal; Drug Utilizat | 2002 |
[Flucytosine - a classical partner for combination therapy].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Mitosporic Fungi; | 2002 |
Clinical pharmacology of antifungal compounds.
Topics: Anti-Bacterial Agents; Antifungal Agents; Drug Design; Echinocandins; Flucytosine; Fungal Proteins; | 2003 |
[Therapeutic safety of antimycotics in the treatment of systemic fungal infections].
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole | 2003 |
Combinations of antifungal agents in therapy--what value are they?
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Caspofungin; Drug Therapy, Combination; Echinoca | 2004 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutica | 2005 |
Antifungal treatment in pediatric patients.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Child; Child, Preschool; Drug Re | 2005 |
Management of systemic fungal infections: alternatives to itraconazole.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Mycoses; Randomized Controlled Trials as Top | 2005 |
[Mechanisms of resistance to antifungal agents].
Topics: Amphotericin B; Antifungal Agents; Azoles; Drug Resistance, Fungal; Flucytosine; Fungi; Humans; Myco | 2007 |
Antifungal agents.
Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucyto | 2007 |
Antifungal serum concentration monitoring: an update.
Topics: Antifungal Agents; Azoles; Echinocandins; Flucytosine; Humans; Monitoring, Physiologic; Mycoses | 2008 |
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.
Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses; Pyrimid | 2008 |
[Action mechanism and resistance of drugs used in visceral mycoses].
Topics: Animals; Antifungal Agents; Candida albicans; Chemical Phenomena; Chemistry; Clotrimazole; Drug Resi | 1980 |
The current status of systemic antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Griseofulvin; Humans; Imidazoles; Ketoconazole; Mico | 1982 |
[Systemic antimycotic treatment].
Topics: Amphotericin B; Drug Therapy, Combination; Flucytosine; Griseofulvin; Humans; Imidazoles; Iodides; K | 1982 |
Antifungal agents used in systemic mycoses. Activity and therapeutic use.
Topics: Amphotericin B; Antifungal Agents; Central Nervous System; Flucytosine; Humans; Imidazoles; Ketocona | 1983 |
Current therapy of pulmonary and disseminated fungal diseases.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Chromoblastomycosis; C | 1983 |
Antifungal agents useful in therapy of systemic fungal infections.
Topics: Amphotericin B; Animals; Antifungal Agents; Binding, Competitive; Cholesterol; Ergosterol; Flucytosi | 1983 |
Antifungal chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Combinations; Flucytosine; Humans; | 1983 |
Antifungal agents used for deep-seated mycotic infections.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cryptococcosis; Flucytosine; Humans; Imidazoles; Myc | 1983 |
[Basis of antifungal chemotherapy].
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Interactions; Drug Resistance, Microbial; Drug Ther | 1983 |
[Current treatment of systematic mycoses].
Topics: Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Flucytosine; | 1983 |
[Antifungal agents].
Topics: Antifungal Agents; Flucytosine; Griseofulvin; Humans; Imidazoles; Mycoses; Phenyl Ethers; Polyenes; | 1981 |
Strategies in the treatment of systemic fungal infections.
Topics: Amphotericin B; Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Microbial; Drug Therapy, | 1980 |
Progress in antimycotic chemotherapy 1945-1980.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Candidiasis; Flucytosine; Humans; Imidazoles; Myco | 1980 |
Treatment of fungal infections of the central nervous system.
Topics: Amphotericin B; Antifungal Agents; Central Nervous System Diseases; Chemical Phenomena; Chemistry; F | 1981 |
Chemotherapy of the systemic mycoses.
Topics: Amphotericin B; Flucytosine; Humans; Imidazoles; Mycoses; Potassium Iodide; Stilbamidines | 1982 |
Mechanisms and clinical impact of antifungal drug resistance.
Topics: Amphotericin B; Azoles; Drug Resistance, Microbial; Flucytosine; Fungi; Humans; Mycoses; Treatment F | 1994 |
Flucytosine--what is its future?
Topics: Amphotericin B; Drug Resistance, Microbial; Drug Therapy, Combination; Flucytosine; Forecasting; Hum | 1995 |
Chemoprophylaxis of fungal infections in neutropenic patients.
Topics: Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Neutropenia; Polyenes; Triazoles | 1994 |
Antifungal therapy: potential interactions with other classes of drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Flu | 1994 |
Fungal peritonitis in patients on peritoneal dialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Drug Administ | 1994 |
Treatment of systemic mycoses in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Flucytosine; Humans; Mycoses; Poly | 1993 |
Cerebral phaeohyphomycosis.
Topics: Adolescent; Biopsy; Brain Abscess; Cerebral Arteries; Cladosporium; Combined Modality Therapy; Crani | 1993 |
New antifungal compounds and strategies for treatment of invasive fungal infections in patients with neoplastic diseases.
Topics: Amphotericin B; Antifungal Agents; Azoles; Flucytosine; Humans; Immunocompromised Host; Mycoses; Neo | 1995 |
Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Flu | 1996 |
[Fungal myocarditis].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Flucytosine; Humans; Mycoses; Myocarditis; Prognosis | 1996 |
Clinical relevance of antifungal resistance.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Cryptococcosis; Drug Resistance, Microbial; | 1997 |
[Commonly used antifungal agents in the treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Top | 1995 |
Therapeutic drug monitoring of systemic antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Drug Monitoring; Flucytosine; Humans; Itraconazole; Mycoses | 1997 |
[Therapy of invasive mycoses in neutropenic patients with hematologic system diseases].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Fluconazol | 1998 |
Fungal infections in iatrogenically compromised hosts.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Catheters, Indwelling; Diagno | 1998 |
Current and future therapy of invasive fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Carriers; Flucytosine; Humans; Liposomes; Mycoses; Triazoles | 1998 |
[Advances in the treatment of severe refractory infections. 4) Deep fungal infection].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Miconazole; Mycos | 1998 |
The challenge of invasive fungal infection.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis | 1999 |
[The future of antifungal agents. Non azole antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Carriers; Echinocandins; Flucytosine; Fungi; Glucos | 1999 |
Therapy of invasive fungal infections.
Topics: Amphotericin B; Antifungal Agents; Catheterization, Central Venous; Contraindications; Drug Therapy, | 1999 |
Systemic antifungal therapy in pediatric practice.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candidiasis; Child; Flucytosine; Griseofulvin; Humans; In | 1999 |
Trichosporon beigelii infection: experience in a regional burn center.
Topics: Adult; Amphotericin B; Antifungal Agents; Burns; Catheters, Indwelling; Drug Resistance, Microbial; | 2000 |
Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions.
Topics: Animals; Antifungal Agents; Drug Interactions; Flucytosine; Fungi; Humans; Mycoses | 2000 |
New antifungal therapy in ophthalmology.
Topics: Antifungal Agents; Candidiasis; Clotrimazole; Eye Diseases; Flucytosine; Humans; Immunotherapy; Myco | 1973 |
Standard antifungal therapy in neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Fever; Flucytosine; Humans; Mycoses; Neutropenia | 2000 |
[Choice and use of antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Flucytosine; Humans; Itr | 2001 |
Flucytosine.
Topics: Amphotericin B; Candidiasis; Chromoblastomycosis; Cryptococcosis; Cytosine; Drug Therapy, Combinatio | 1977 |
5-fluorocytosine: a brief review.
Topics: Candidiasis; Cytosine; Drug Resistance; Drug Therapy, Combination; Flucytosine; Humans; Mycoses | 1977 |
Antifungal agents: recent developments.
Topics: Amphotericin B; Antifungal Agents; Cell Membrane; Chemical Phenomena; Chemistry; Clotrimazole; Drug | 1977 |
Chemotherapy of systemic fungal diseases.
Topics: Amphotericin B; Animals; Eukaryota; Flucytosine; Helminths; Humans; Miconazole; Mycoplasma; Mycoses; | 1978 |
[Progress in the therapy of systemic mycoses].
Topics: Amphotericin B; Aspergillus; Candida; Clotrimazole; Cryptococcus; Drug Therapy, Combination; Flucyto | 1978 |
Treatment of opportunistic systemic mycoses.
Topics: Amphotericin B; Cytosine; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Fl | 1978 |
Opportunistic invasive fungal infections in patients with leukaemia lymphoma.
Topics: Acute Disease; Adrenal Cortex Hormones; Amphotericin B; Aspergillosis; Blood Transfusion; Candidiasi | 1976 |
Genitourinary fungal infections.
Topics: Amphotericin B; Animals; Candida; Candidiasis; Female; Flucytosine; Genital Diseases, Female; Genita | 1976 |
Antifungal treatment strategy in leukemia patients.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itra | 1992 |
[Systemic antifungal drugs].
Topics: Amphotericin B; Animals; Antifungal Agents; Flucytosine; Humans; In Vitro Techniques; Itraconazole; | 1991 |
Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.
Topics: Amphotericin B; Antifungal Agents; Azoles; Drug Resistance, Microbial; Drugs, Investigational; Flucy | 1992 |
Cerebral phaeohyphomycosis caused by Xylohypha bantiana, with a review of the literature.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antibodies, Fungal; Brain Abscess; Child; Cladosporium; Fem | 1992 |
Phaeohyphomycosis due to Exophiala species: clinical spectrum of disease in humans.
Topics: Adult; Amphotericin B; Combined Modality Therapy; Drug Administration Schedule; Drug Therapy, Combin | 1992 |
Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy.
Topics: Adolescent; Adult; Amphotericin B; Child, Preschool; Drug Therapy, Combination; Female; Flucytosine; | 1992 |
Laboratory monitoring of antifungal chemotherapy. British Society for Antimicrobial Chemotherapy Working Party.
Topics: Adult; Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Drug Resistance; Dru | 1991 |
Antifungal agents used for deep-seated mycotic infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Thromboxane-A Synthase; | 1992 |
Fungemia in a university hospital 1984-1988. Clinical and mycological characteristics.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Child; Ch | 1991 |
Combination therapy in systemic mycosis.
Topics: Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Drug Synergism; Drug Therapy, Combinatio | 1990 |
[The antimycotic drugs].
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses | 1989 |
Fungal peritonitis caused by Curvularia lunata in a patient undergoing peritoneal dialysis.
Topics: Bacterial Infections; Catheters, Indwelling; Flucytosine; Humans; Male; Middle Aged; Mitosporic Fung | 1989 |
Recent advances in the treatment of systemic fungal infections.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; D | 1987 |
Treatment of systemic fungal infections: recent progress and current problems.
Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans; | 1988 |
Diagnosis and successful treatment of fusariosis in the compromised host.
Topics: Adult; Amphotericin B; Female; Flucytosine; Fusarium; Humans; Immune Tolerance; Leukemia; Leukemia, | 1988 |
Topical and systemic antifungal agents.
Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Dermatomycoses; Flucytosine; Humans; Ket | 1988 |
Cutaneous and mucosal manifestations of the deep mycotic infections.
Topics: Amphotericin B; Aspergillosis; Blastomycosis; Candidiasis; Candidiasis, Cutaneous; Coccidioidomycosi | 1986 |
Mode of action of clinically important antifungal drugs.
Topics: Allylamine; Antifungal Agents; Candida albicans; Cell Membrane; Cell Nucleus; Cell Wall; Dermatomyco | 1986 |
Nephrotoxicity of antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Dermatomycoses; Flucytosine; Grise | 1985 |
Pharmacokinetics of the treatment of fungal infections.
Topics: Alkenes; Amphotericin B; Animals; Antifungal Agents; Aspergillus; Benzene Derivatives; Candida; Derm | 1972 |
Therapy of fungal infections.
Topics: Administration, Topical; Amphotericin B; Candidiasis; Coccidioides; Flucytosine; Fusarium; Griseoful | 1973 |
Therapy with amphotericin B and other new antifungal agents.
Topics: Alkenes; Amphotericin B; Animals; Antifungal Agents; Flucytosine; Humans; Injections, Intravenous; M | 1974 |
[Chemotherapy of deep mycoses (a review of the literature)].
Topics: Amphotericin B; Antifungal Agents; Chronic Disease; Flucytosine; Humans; Imidazoles; Mycoses; Natamy | 1973 |
Drug treatment of the systemic mycoses.
Topics: Actinomycosis; Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidi | 1972 |
6 trials available for flucytosine and Mycoses
Article | Year |
---|---|
[A comparative clinical study on flucytosine alone and in combination with fluconazole in hematological malignancies: a multicenter study using the envelope method].
Topics: Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Glucans | 1994 |
Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fluco | 1999 |
Antifungal therapy, 1978.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Clinical Trials as Topic; Flucytosine; History, 18 | 1979 |
[Flucytosine in the treatment of urinary fungal infections. Clinical efficacy and background factors].
Topics: Adult; Aged; Aged, 80 and over; Candida; Female; Flucytosine; Humans; Immune Tolerance; Male; Middle | 1991 |
Combination therapy in systemic mycosis.
Topics: Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Drug Synergism; Drug Therapy, Combinatio | 1990 |
[5-Flour-ocytosin as treatment agent in genital mycosis (author's transl)].
Topics: Candida albicans; Cytosine; Drug Evaluation; Female; Flucytosine; Humans; Mycoses; Nystatin; Vaginal | 1974 |
189 other studies available for flucytosine and Mycoses
Article | Year |
---|---|
Combined therapies in a murine model of blastoschizomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Sy | 2007 |
Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Culture Media; Drug Resistance, Fungal; Fungi; H | 2008 |
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; | 2009 |
[Comment on this case report].
Topics: Adult; Amphotericin B; Antifungal Agents; Buprenorphine; Candidiasis; Endocarditis; Endophthalmitis; | 2012 |
Five-year retrospective review of guideline-based management of fungal endophthalmitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Costs; Endophthalmitis; Eye Infecti | 2008 |
Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cross Infection; Dermatomycoses; Drug Resistance, Fungal; | 2008 |
Combined antifungal therapy in a murine model of disseminated infection by Cladophialophora bantiana.
Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Disease Models, Animal; Drug Therapy, Combin | 2009 |
Identification of Paecilomyces variotii in clinical samples and settings.
Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Flucytosine; | 2010 |
In vitro analysis of antifungal impregnated polymethylmethacrylate bone cement.
Topics: Amphotericin B; Antifungal Agents; Arthroplasty, Replacement; Bone Cements; Candida; Colony Count, M | 2002 |
Nosocomial transmission of Saccharomyces cerevisiae in bone marrow transplant patients.
Topics: Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Carrier State; Cross Infectio | 2002 |
Antifungal drug resistance.
Topics: Antifungal Agents; Azoles; Biological Transport; DNA-Binding Proteins; Drug Resistance, Microbial; E | 2003 |
Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera.
Topics: Adult; Antifungal Agents; Drug Therapy, Combination; Exophiala; Female; Flucytosine; Humans; Itracon | 2004 |
[In vitro activity of a new semisynthetic echinocandin, micafungin, against clinical isolates of Candida species isolated in Tenri Hospital].
Topics: Amphotericin B; Antifungal Agents; Candida; DNA Fingerprinting; Drug Resistance, Fungal; Echinocandi | 2003 |
In vitro susceptibility of Candida species isolated from cancer patients to some antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Disease Susceptibility; Fluconazole; Flucytosine; Humans | 2004 |
[Allergic fungal sinusitis and allergic broncho-pulmonary aspergillosis: a fortuitous association or a nosological rhino-bronchial entity?].
Topics: Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Combined Modality T | 2005 |
Antimycotic combination therapy in patients with acute myeloblastic leukemia.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Administration Schedule; Drug Thera | 1989 |
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Huma | 2006 |
Successful treatment of Trichosporon mucoides infection with lipid complex amphotericin B and 5-fluorocytosine.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Male; | 2006 |
Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory.
Topics: Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Flucytosine; Humans; Infant; Infant, Ne | 2006 |
Endophthalmitis due to Trichosporon beigelii in acute leukemia.
Topics: Acute Disease; Adult; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Endophthalmitis; F | 2007 |
Antimycotic therapy of experimental infections caused by dematiaceous fungi.
Topics: Amphotericin B; Animals; Antifungal Agents; Dose-Response Relationship, Drug; Drug Therapy, Combinat | 1984 |
Effective systemic antifungal agents.
Topics: Administration, Oral; Amphotericin B; Cytosine; Drug Evaluation; Drug Resistance, Microbial; Flucyto | 1984 |
Subcutaneous phaeohyphomycosis caused by Exophiala spinifera.
Topics: Flucytosine; Humans; Ketoconazole; Middle Aged; Mitosporic Fungi; Mycoses; Skin; Species Specificity | 1984 |
[A study on urinary fungal infection].
Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Bicarbonates; Candida; Candidiasis; | 1983 |
Brain abscess caused by a variety of cladosporium trichoides.
Topics: Amphotericin B; Brain Abscess; Cladosporium; Flucytosine; Humans; Male; Middle Aged; Mitosporic Fung | 1983 |
Drugs for treatments of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Ketoconazole; Miconazole; Mycose | 1982 |
Antimicrobial treatment of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Ketoconazole; Miconazole; Mycose | 1983 |
Drugs for treatment of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Ketoconazole; Mic | 1984 |
Antimycotic activity of BAY N 7133 in animal experiments.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergill | 1984 |
Systemic infection by Rhodotorula spp. in the immunocompromised host.
Topics: Adult; Amphotericin B; Bone Marrow; Flucytosine; Humans; Ketoconazole; Leukemia, Myeloid, Acute; Liv | 1984 |
Susceptibility of fungi in mouthrinse specimens from patients with haematological malignancies.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Flucyto | 1984 |
[Fungal sepsis and DIC in surgical patients].
Topics: Adult; Aged; Amphotericin B; Disseminated Intravascular Coagulation; Female; Flucytosine; Gabexate; | 1983 |
[Antimycotic chemotherapy in weakened resistance].
Topics: Amphotericin B; Antifungal Agents; Azo Compounds; Disease Susceptibility; Flucytosine; Humans; Immun | 1984 |
Fungal peritonitis in ambulatory peritoneal dialysis.
Topics: Candida; Candidiasis; Flucytosine; Humans; Mycoses; Peritoneal Dialysis; Peritoneal Dialysis, Contin | 1984 |
Infection of the olecranon bursa by Anthopsis deltoidea.
Topics: Aged; Bursa, Synovial; Bursitis; Combined Modality Therapy; Elbow Joint; Flucytosine; Humans; Male; | 1984 |
Torulopsis glabrata peritonitis complicating continuous ambulatory peritoneal dialysis: successful management with oral 5-fluorocytosine.
Topics: Aged; Candida; Female; Flucytosine; Humans; Male; Mycoses; Peritoneal Dialysis; Peritoneal Dialysis, | 1984 |
Trichosporon hepatitis.
Topics: Adult; Amphotericin B; Aspergillosis; Biopsy; Female; Flucytosine; Hepatitis; Humans; Leukemia, Myel | 1983 |
Trichosporon capitatum: thrush-like oral infection, local invasion, fungaemia and metastatic abscess formation in a leukaemic patient.
Topics: Abscess; Adult; Amphotericin B; Blood; Female; Flucytosine; Humans; Leukemia, Myeloid, Acute; Mitosp | 1983 |
Drug therapy of systemic fungal infections, Part II.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Miconazole; Mycoses | 1984 |
Torulopsis infection extensively involving urinary tract.
Topics: Amphotericin B; Biopsy; Candida; Flucytosine; Humans; Male; Middle Aged; Mycoses; Therapeutic Irriga | 1983 |
Disseminated fungal infections in very low-birth-weight infants: therapeutic toxicity.
Topics: Acute Kidney Injury; Amphotericin B; Cytosine; Flucytosine; Humans; Infant; Infant, Low Birth Weight | 1984 |
Managing fungal infections.
Topics: Anti-Infective Agents, Local; Antifungal Agents; Dermatomycoses; Flucytosine; Humans; Imidazoles; Im | 1984 |
Acute monoarticular arthritis due to Phialophora parasitica.
Topics: Arthritis, Infectious; Biopsy, Needle; Flucytosine; Humans; Knee Joint; Male; Middle Aged; Mycoses; | 1983 |
[Antimycotic therapy. 1: Classification, antimycotic drugs: flucytosine, tolnaftate].
Topics: Antifungal Agents; Cytosine; Flucytosine; Humans; Mycoses; Tolnaftate | 1983 |
Drugs for fungal infections.
Topics: Adult; Amphotericin B; Antifungal Agents; Child; Flucytosine; Griseofulvin; Humans; Miconazole; Myco | 1980 |
Cerebral abscess caused by Cladosporium bantianum. Case report.
Topics: Amphotericin B; Brain Abscess; Cladosporium; Female; Flucytosine; Humans; Hydrocephalus; Microbiolog | 1982 |
Treatment of systemic fungus infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Miconazole; Mycoses | 1982 |
The measurement of serum 5-fluorocytosine levels in the presence of miconazole.
Topics: Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Miconazole; Mycoses | 1982 |
[Antifungal agents in otorhinolaryngology].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Mycos | 1982 |
Infectious complications in the child with cancer. II. Management of specific infectious organisms.
Topics: Amphotericin B; Bacterial Infections; Child; Flucytosine; Humans; Infections; Mycoses; Neoplasms; Pr | 1981 |
[Therapy of systemic mycoses].
Topics: Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Polyenes | 1981 |
[Management of visceral mycoses, with special reference to drug therapy].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Flucytosine; Humans; Lung Diseases, F | 1980 |
[Present status and future prospect in the studies of antifungal agents].
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Flucytosine; Humans; Imidazoles; Mycoses | 1981 |
[New pharmaceuticals in systemic mycoses (author's transl)].
Topics: Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; D | 1981 |
Practical therapeutics chemotherapy of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Evaluation; Flucytosine; Griseofulvin; Humans; Mycoses | 1981 |
[Microbial sensitivity tests with antifungal agents and their determination in body fluids].
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Microbial Sensitivity Tests; Mycoses | 1981 |
[Treatment of systemic mycoses].
Topics: Amphotericin B; Cytosine; Flucytosine; Humans; Mycoses | 1981 |
Treating fungal infections.
Topics: Amphotericin B; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Mycoses | 1980 |
Fungal cystitis: awareness, diagnosis and treatment.
Topics: Amphotericin B; Candidiasis; Cystitis; Female; Flucytosine; Humans; Male; Middle Aged; Mycoses | 1980 |
Subcutaneous infection with phialophora richardsiae and its susceptibility to 5-fluorocytosine, amphotericin B and miconazole.
Topics: Adult; Aged; Amphotericin B; Cycloheximide; Cytosine; Drug Resistance, Microbial; Flucytosine; Human | 1980 |
Intracatheter amphotericin B retention for fungal peritonitis in continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Amphotericin B; Catheters, Indwelling; Drug Therapy, Combination; Female; Fluc | 1995 |
Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method.
Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Colony Count, Microbia | 1995 |
In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method.
Topics: Amphotericin B; Antifungal Agents; Candida; Dose-Response Relationship, Drug; Fluconazole; Flucytosi | 1995 |
Association therapy as a prognostic factor in deep fungal infection complicating oncohaematological diseases.
Topics: Adolescent; Adult; Amphotericin B; Aspergillosis; Aspergillus; Bronchoalveolar Lavage Fluid; Cryptoc | 1994 |
Verticillium peritonitis in a patient on peritoneal dialysis.
Topics: Adult; Fluconazole; Flucytosine; Humans; Male; Mitosporic Fungi; Mycoses; Peritoneal Dialysis, Conti | 1994 |
Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis, Vulvovaginal; Fem | 1994 |
[In vitro susceptibility to fluconazole of fungal strains freshly isolated from child patients with deep-seated mycoses].
Topics: Amphotericin B; Aspergillus; Candida; Child; Drug Resistance, Microbial; Fluconazole; Flucytosine; H | 1993 |
Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Azoles; Flucytosine; Humans; | 1993 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole | 1994 |
[Fungal meningitis caused by a Malassezia species masquerading as painful ophthalmoplegia].
Topics: Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; M | 1993 |
Pharmacokinetics of antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Ketoconazole; Mycoses; Peritone | 1993 |
Successful treatment of fungal peritonitis with intracatheter antifungal retention.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Catheters, Indwelling; Female; Fluconazole; Flucytos | 1995 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole | 1996 |
Trichoderma harzianum peritonitis in peritoneal dialysis.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Bacterial Infections; Diabetes Mellitus, Type 2; Diabeti | 1996 |
[Focusing on therapy of systemic mycoses].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Dose-Response | 1995 |
Atypical eumycetoma caused by Phialophora parasitica successfully treated with itraconazole and flucytosine.
Topics: Adult; Antifungal Agents; Drug Therapy, Combination; Female; Flucytosine; Foot Diseases; Humans; Itr | 1997 |
Saccharomyces cerevisiae infections and antifungal susceptibility studies by colorimetric and broth macrodilution methods.
Topics: Amphotericin B; Antifungal Agents; Colorimetry; Fatal Outcome; Female; Fluconazole; Flucytosine; Hum | 1995 |
Therapy of deep fungal infection in haematological malignancy. Working Party of the British Society for Antimicrobial Chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Hematologic Neoplasms; Humans; Mycoses | 1997 |
Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity T | 1998 |
In vitro and in vivo experimental activities of antifungal agents against Fusarium solani.
Topics: Amphotericin B; Animals; Antibiotics, Antitubercular; Antifungal Agents; Drug Therapy, Combination; | 1999 |
[A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)].
Topics: Adult; Age Factors; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross-Sectional S | 1999 |
Systemic phaeohyphomycosis in pregnancy and the puerperium.
Topics: Adult; Antifungal Agents; Ascomycota; Female; Flucytosine; Humans; Itraconazole; Mycoses; Pregnancy; | 2000 |
Disseminated Penicillium marneffei infection in an HIV-positive female from Thailand in Germany.
Topics: Adult; Amphotericin B; Anti-HIV Agents; Antifungal Agents; CD4 Lymphocyte Count; Cross Reactions; Dr | 1999 |
Antimicrobial susceptibility testing of dematiaceous filamentous fungi: effect of medium composition at different temperatures and times of reading.
Topics: Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Flucytosine; Fungi; Hot T | 1999 |
[Visceral mycotic infections. In clinical practice].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cryptococcosis; Fluconazole; Flucytosine; Histoplasm | 2001 |
[Fungal infections in intensive care units: a cross-survey].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Data Collection; Fluconazole; Flucy | 2001 |
Trichosporon sepsis and leukemia.
Topics: Amphotericin B; Anti-Bacterial Agents; Bleomycin; Child; Cytarabine; Enterobacteriaceae Infections; | 1975 |
Torulopsis glabrata--urinary tract infections in diabetic patients in Singapore.
Topics: Adult; Aged; Amphotericin B; Candida; Diabetes Complications; Female; Flucytosine; Humans; Middle Ag | 1977 |
Maxillary sinus infection with Allescheria boydii (Petriellidium boydii).
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Face; Flucytosine; Humans; Leukemia, Lymphoid; Male; M | 1978 |
Treatment of systemic mycoses. Panel discussion.
Topics: Amphotericin B; Cytosine; Drug Evaluation; Drug Resistance, Microbial; Flucytosine; Humans; Mycoses | 1978 |
Mycotic wound infections. A new challenge of the surgeon.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Female; Flucytosine; Humans; Leukemia, | 1979 |
[Diagnosis and therapy of generalized mycoses].
Topics: Amphotericin B; Flucytosine; Humans; Mycoses; Natamycin; Nystatin; Serologic Tests; Skin Tests; Spec | 1978 |
Therapy of postsurgical fungal endophthalmitis.
Topics: Aged; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Cataract Extraction; Eye Diseases; | 1978 |
Fusarium oxysporum endophthalmitis.
Topics: Adult; Amphotericin B; Drug Resistance, Microbial; Drug Therapy, Combination; Electroretinography; E | 1979 |
[Fungal infections following renal transplantation].
Topics: Amphotericin B; Flucytosine; Humans; Immunosuppression Therapy; Kidney Transplantation; Miconazole; | 1977 |
Recent advances in the treatment of systemic mycotic infections.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Flucytosine; | 1979 |
Diagnosis and management of opportunistic infections. Part II. Diagnosis and therapy.
Topics: Amphotericin B; Anaerobiosis; Anti-Infective Agents; Bacterial Infections; Flucytosine; Humans; Infe | 1977 |
[Therapy of opportunistic mycoses].
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Evaluation; Econazole; Flucytosine; Humans; Miconazol | 1979 |
[Recent progress in the treatment of systemic mycotic infections].
Topics: Antifungal Agents; Clotrimazole; Econazole; Flucytosine; Humans; Miconazole; Mycoses | 1979 |
Mycoses imported from the West Indies. A report of three cases.
Topics: Adult; Chromoblastomycosis; Emigration and Immigration; Female; Flucytosine; Histoplasmosis; Humans; | 1979 |
The role of chemotherapy in the management of fungal endocaridits following homograft valve replacement.
Topics: Amphotericin B; Endocarditis; Flucytosine; Heart Valves; Humans; Mycoses; Postoperative Complication | 1979 |
Clearance of amphotericin B and 5-fluorocytosine by peritoneal dialysis.
Topics: Amphotericin B; Ascitic Fluid; Cryptococcus; Cytosine; Flucytosine; Humans; Kidney Failure, Chronic; | 1979 |
Torulopsis glabrata fungaemia. A report of two cases.
Topics: Adult; Amphotericin B; Candida; Drug Therapy, Combination; Flucytosine; Humans; Male; Middle Aged; M | 1977 |
[Iatrogenic mycoses with deep visceral localization caused by opportunistic fungi].
Topics: Amphotericin B; Candida; Candidiasis; Cryptococcosis; Dermatomycoses; Endocarditis; Flucytosine; Hum | 1979 |
The current status of chemotherapeutic agents for the systemic mycoses.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Clotrimazole; Flucytosine; Humans; Miconazole; Myc | 1977 |
[Incidence and therapy of fungal infections of the efferent urinary pathways].
Topics: Aged; Female; Flucytosine; Germany, East; Humans; Mycoses; Pyelonephritis; Urinary Tract Infections; | 1977 |
[Clinical results in the management of mycoses using 5-fluorocytosine].
Topics: Age Factors; Antifungal Agents; Candidiasis; Child; Cytosine; Flucytosine; Humans; Mycoses | 1977 |
[Results of cellular immune reaction assessment under 5-fluorocytosine therapy].
Topics: Child; Cytosine; Flucytosine; Humans; Immunity, Cellular; Lymphocyte Activation; Mycoses | 1977 |
[Microbiological and clinical aspects of antifungal therapy].
Topics: Amphotericin B; Animals; Antifungal Agents; Arthrodermataceae; Dermatomycoses; Drug Resistance, Micr | 1977 |
[Critical remarks to the hospital on antifungal chemotherapy].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Mycos | 1977 |
[Combination of amphotericin B and 5-fluorocytosine].
Topics: Amphotericin B; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Mycoses | 1978 |
Drugs for the treatment of systemic fungal infections.
Topics: Amphotericin B; Clotrimazole; Drug Therapy, Combination; Flucytosine; Humans; Kidney Diseases; Menin | 1978 |
Combined treatment with amphotericin B and flucytosine in severe fungal infections.
Topics: Adult; Aged; Amphotericin B; Candida albicans; Candidiasis; Cytosine; Drug Therapy, Combination; Eye | 1976 |
Bone marrow toxicity associated with 5-fluorocytosine therapy.
Topics: Adult; Aged; Bone Marrow Diseases; Cytosine; Female; Flucytosine; Humans; Kidney Diseases; Leukopeni | 1977 |
Amphotericin B: a second look.
Topics: Amphotericin B; Animals; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Fl | 1977 |
[New Drugs: Ancotil Roche].
Topics: Chemical Phenomena; Chemistry; Cytosine; Flucytosine; Humans; Mycoses | 1977 |
[5-fluorocytosine--a new antimycotic drug].
Topics: Chemical Phenomena; Chemistry; Cytosine; Drug Evaluation; Flucytosine; Humans; Microbial Sensitivity | 1976 |
Brain abscess caused by Cladosporium trichoides.
Topics: Adolescent; Adult; Autopsy; Brain Abscess; Cladosporium; Female; Flucytosine; Humans; Male; Middle A | 1976 |
Visceral fungal infections due to Petriellidium boydii (allescheria boydii). In vitro drug sensitivity studies.
Topics: Adult; Aged; Amphotericin B; Ascomycota; Disease Susceptibility; Female; Flucytosine; Humans; Male; | 1976 |
[Therapy of generalized juvenile mycoses].
Topics: Amphotericin B; Antifungal Agents; Child; Clotrimazole; Drug Resistance; Flucytosine; Griseofulvin; | 1976 |
[Treatment of mycoses in children with 5-fluorocytosine].
Topics: Child; Child, Preschool; Cytosine; Drug Evaluation; Female; Flucytosine; Humans; Infant; Infant, New | 1976 |
Brain abscess caused by Cladosporium trichoides (Bantianum): a case with paranasal sinus involvement.
Topics: Brain Abscess; Cladosporium; Flucytosine; Humans; Male; Middle Aged; Mitosporic Fungi; Mycoses; Sinu | 1976 |
New drugs for the systemic mycoses: flucytosine and clotrimazole.
Topics: Clotrimazole; Cytosine; Flucytosine; Humans; Imidazoles; Mycoses | 1975 |
Amphotericin B. Old drug, new therapy.?2110.
Topics: Adjuvants, Immunologic; Amphotericin B; Animals; Candida albicans; Cell Membrane Permeability; Crypt | 1975 |
Editoral: Treatment of fungal infections.
Topics: Amphotericin B; Aspergillus; Candida; Candida albicans; Cryptococcus neoformans; Cytosine; Drug Ther | 1975 |
Fungal infection following renal transplantation.
Topics: Adolescent; Adult; Amphotericin B; Antibodies, Fungal; Aspergillosis; Bacterial Infections; Candidia | 1975 |
Flucytosine.
Topics: Cytosine; Flucytosine; Humans; Mycoses | 1975 |
New antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Chlorobenzenes; Clotrimazole; Flucytosine; Humans; Imidazoles; Me | 1975 |
Invasive fungal infection in the immunosuppressed host.
Topics: Amphotericin B; Anti-Bacterial Agents; Aspergillosis; Candidiasis; Clotrimazole; Cryptococcosis; Flu | 1975 |
Therapeutic usefulness. 5-Fluorocytosine--a new anti-fungal agent.
Topics: Adult; Aged; Amphotericin B; Candida; Cryptococcosis; Cytosine; Drug Therapy, Combination; Female; F | 1975 |
Fungal endocarditis: analysis of 24 cases and review of the literature.
Topics: Adolescent; Adult; Aged; Amphotericin B; Aspergillosis; Candida; Candidiasis; Cardiac Surgical Proce | 1975 |
[Current problems and new developments in therapy of mycoses (author's transl)].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Clotrimazole; Cryptococcosis; Dermatomycoses; Drug R | 1975 |
[Therapeutic use of antimycotic substances].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Burns; Cardiac Surgical Procedures; Cathet | 1976 |
[Identification and special treatment of generalized mycoses].
Topics: Amphotericin B; Clotrimazole; Flucytosine; Humans; Mycoses | 1976 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole | 1992 |
Tropical mycoses.
Topics: Adult; Aged; Antifungal Agents; Blastomycosis; Chromoblastomycosis; Drug Therapy, Combination; Femal | 1992 |
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy | 1992 |
Hyalohyphomycosis caused by Paecilomyces variotii: a case report, animal pathogenicity and 'in vitro' sensitivity.
Topics: Adult; Animals; Antifungal Agents; Cortisone; Dermatomycoses; Flucytosine; Humans; Immunocompromised | 1992 |
[Clinical evaluation of flucytosine in patients with urinary fungal infections].
Topics: Adult; Aged; Aged, 80 and over; Candida; Candidiasis; Drug Evaluation; Drug Resistance, Microbial; F | 1992 |
Phaeohyphomycotic brain abscess due to Ochroconis gallopavum in a patient with malignant lymphoma of a large cell type.
Topics: Amphotericin B; Brain; Brain Abscess; Fluconazole; Flucytosine; Humans; Lymphoma, Large B-Cell, Diff | 1991 |
Aureobasidium infection of the jaw.
Topics: Adult; Flucytosine; Humans; Male; Mandibular Diseases; Mitosporic Fungi; Molar, Third; Mycoses; Oste | 1991 |
[Drug therapy of intractable mycoses].
Topics: Administration, Oral; Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Flucy | 1990 |
[Endophthalmitis due to Fusarium: an uncommon cause].
Topics: Adult; Amphotericin B; Endophthalmitis; Female; Flucytosine; Fusarium; Humans; Mycoses; Vitrectomy | 1990 |
Preliminary results of treatment with itraconazole in patients with systemic fungal infections.
Topics: Acute Disease; Adult; Agranulocytosis; Antifungal Agents; Antineoplastic Agents; Drug Evaluation; Dr | 1990 |
Treating systemic fungal infections in AIDS patients. Prolonging life against the odds.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Azoles; Candidiasis; Cryptoco | 1990 |
[Antifungal agents].
Topics: Administration, Oral; Amphotericin B; Fluconazole; Flucytosine; Humans; Infusions, Intravenous; Inje | 1990 |
Fusarium peritonitis in peritoneal dialysis: report of two cases.
Topics: Aged; Catheters, Indwelling; Female; Flucytosine; Fusarium; Humans; Male; Mycoses; Peritoneal Dialys | 1990 |
Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates.
Topics: Amphotericin B; Candidiasis; Flucytosine; Gestational Age; Humans; Infant, Low Birth Weight; Infant, | 1990 |
First report of chronic meningitis caused by Trichosporon beigelii.
Topics: Adolescent; Amphotericin B; Chronic Disease; Drug Therapy, Combination; Fluconazole; Flucytosine; Hu | 1990 |
Two cases of disseminated Trichosporon beigelii infection treated with combination antifungal therapy.
Topics: Adult; Amphotericin B; Drug Combinations; Flucytosine; Humans; Leukemia, Myeloid, Acute; Lymphoma, N | 1990 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Ketoconazole | 1990 |
A case of disseminated phaeohyphomycosis caused by Cladosporium devriesii.
Topics: Adult; Amphotericin B; Cause of Death; Cladosporium; Female; Flucytosine; Humans; Mycoses; Recurrenc | 1990 |
[Mycoses in otorhinolaryngology. Apropos of 167 cases].
Topics: Adult; Antifungal Agents; Child; Child, Preschool; Cote d'Ivoire; Female; Flucytosine; Humans; Infan | 1989 |
[Treatment of mycoses and new antifungal agents].
Topics: Allylamine; Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Flucytosine; Humans; Itra | 1989 |
Fungal peritonitis in children on continuous ambulatory peritoneal dialysis.
Topics: Adolescent; Amphotericin B; Candidiasis; Child; Child, Preschool; Cryptococcosis; Female; Flucytosin | 1989 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy | 1987 |
Infection and colonisation of neonates by Hansenula anomala.
Topics: Amphotericin B; Disease Outbreaks; Drug Therapy, Combination; England; Flucytosine; Gestational Age; | 1986 |
[Decrease in systemic fungal infections in hematological neoplasms with empirical use of amphotericin B therapy].
Topics: Amphotericin B; Creatinine; Drug Therapy, Combination; Flucytosine; Humans; Leukemia, Myeloid, Acute | 1989 |
Intracranial phycomycosis: case reports.
Topics: Adult; Amphotericin B; Biopsy; Brain Diseases; Female; Flucytosine; Humans; Male; Middle Aged; Mycos | 1988 |
Chemotherapy of the pulmonary mycoses. This Official Statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1987.
Topics: Amphotericin B; Flucytosine; Humans; Imidazoles; Lung Diseases; Mycoses; Triazoles | 1988 |
Parenteral 5-fluorocytosine in the therapy of systemic mycoses.
Topics: Amphotericin B; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Infant, | 1988 |
Drugs for treatment of deep fungal infection.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Humans; Ketoconazole; Mycoses; Op | 1988 |
Rhodotorula rubra ventriculitis.
Topics: Adult; Amphotericin B; Cerebral Ventricles; Encephalitis; Female; Flucytosine; Humans; Immune Tolera | 1988 |
[Antimycotic agents in generalized fungal infections].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Mycos | 1988 |
Successful treatment of disseminated Trichosporon beigelii (cutaneum) infection with associated splenic involvement.
Topics: Adult; Amphotericin B; Combined Modality Therapy; Flucytosine; Humans; Leukemia, Monocytic, Acute; M | 1986 |
[Fungal urinary infection: report no. 1].
Topics: Adult; Aged; Aged, 80 and over; Candida; Drug Resistance, Microbial; Flucytosine; Humans; Middle Age | 1986 |
Cerebral phaeohyphomycosis.
Topics: Amphotericin B; Brain Abscess; Cladosporium; Drug Therapy, Combination; Female; Flucytosine; Humans; | 1987 |
The high morbidity of CAPD fungal peritonitis--description of 10 cases and review of treatment strategies.
Topics: Adult; Aged; Amphotericin B; Catheters, Indwelling; Female; Flucytosine; Humans; Kidney Failure, Chr | 1986 |
Antifungal agents used for deep-seated mycotic infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Triazoles | 1987 |
In-vitro evaluation of antifungal agents in the treatment of yeast peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD).
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Drug Evaluation; Flucytosine; Human | 1987 |
Fungal endophthalmitis in narcotic abusers. Medical and surgical therapy in 10 patients.
Topics: Adult; Amphotericin B; Candidiasis; Drug Therapy, Combination; Endophthalmitis; Female; Flucytosine; | 1985 |
Ketoconazole: clinical evaluation in severe fungal infections.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Male; | 1986 |
Drugs for treatment of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Flucytosine; Humans | 1986 |
Fungal peritonitis in patients on peritoneal dialysis: incidence, clinical features and prognosis.
Topics: Adult; Aged; Amphotericin B; Catheters, Indwelling; Drug Therapy, Combination; Female; Flucytosine; | 1985 |
Chemotherapy and/or removal of the peritoneal catheter in the management of fungal peritonitis complicating CAPD?
Topics: Candida; Catheters, Indwelling; Flucytosine; Humans; Mycoses; Peritoneal Dialysis; Peritoneal Dialys | 1985 |
Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Three recoveries in 5 cases without catheter removal.
Topics: Adult; Aged; Amphotericin B; Catheterization; Drug Therapy, Combination; Female; Flucytosine; Humans | 1985 |
Deep scopulariopsosis: a case report and sensitivity studies.
Topics: Adult; Amphotericin B; Ankle Joint; Antimony; Chronic Disease; Female; Flucytosine; Granulation Tiss | 1974 |
Fungal infections.
Topics: Antifungal Agents; Culture Media; Drug Resistance, Microbial; Drug Stability; Flucytosine; Fungi; Hu | 1974 |
Current and future chemotherapy of central nervous system fungal infections.
Topics: Administration, Oral; Amphotericin B; Arrhythmias, Cardiac; Brain Diseases; Cytosine; Flucytosine; G | 1974 |
Chemotherapy of the systemic mycoses.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Flucytosine; H | 1973 |
Systemic mycoses in children. II.
Topics: Actinomycosis; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Female; | 1972 |
Postoperative fungal endocarditis. Fungemia, embolism, and therapy.
Topics: Aged; Amphotericin B; Aortic Valve; Aspergillus; Blood; Candida; Candida albicans; Cryptococcus; Emb | 1974 |
Therapy of deep-seated fungal infections with 5-fluorocytosine.
Topics: Adult; Aged; Amphotericin B; Anterior Chamber; Aspergillosis; Aspergillus fumigatus; Candida albican | 1974 |
Synergism of amphotericin B with other antimicrobial agents.
Topics: Amphotericin B; Antifungal Agents; Cytosine; Drug Synergism; Flucytosine; Humans; Mycoses; Rifampin | 1973 |
Treatment of systemic mycoses.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidomycosis; Cr | 1973 |
The treatment of systemic mycoses.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Mycoses; Potassium Iodide; Stilbamidines | 1973 |
Experimental therapy of cladosporiosis and sporotrichosis with 5-fluorocytosine.
Topics: Animals; Antifungal Agents; Cytosine; Flucytosine; Male; Mice; Mitosporic Fungi; Mycoses; Sporotrich | 1973 |
Bronchopulmonary geotrichosis.
Topics: Aged; Amphotericin B; Bronchial Diseases; Colistin; Flucytosine; Geotrichosis; Humans; Lung Diseases | 1973 |
Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man.
Topics: Adult; Amphotericin B; Antifungal Agents; Blood Proteins; Cholesterol; Creatinine; Cytosine; Flucyto | 1974 |